ORKA

Arjun Agarwal

Known title: Senior Vice President, FinanceCIK: 0002033974

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 7, 2026

HC Wainwright Reiterates $120 Target on Oruka. HC Wainwright maintained its buy rating on Oruka Therapeutics, keeping its price target at $120. The firm continues to see the company favorably despite recent trading levels well below that target. The analyst consensus average for the stock stands at $153.75, with estimates ranging from $102 to $200.

this person other insiders at ORKA

Transaction History

ORKA▼ Sell$51K
ORKA▼ Sell$54K
ORKA▲ Buy$100K
ORKA▲ Buy$50K
ORKA▼ Sell$273K
ORKA▼ Sell$374K
ORKA▼ Sell$206K
ORKA▼ Sell$19K
ORKA▼ Sell$256K
ORKA▼ Sell$231K
ORKA▼ Sell$225K
ORKA▼ Sell$135K
ORKA▲ Buy$107K
ORKA▲ Buy$50K
ORKA▼ Sell$220K
ORKA▲ Buy$50K
ORKA▼ Sell$25K
ORKA▼ Sell$315K
ORKA▲ Buy$107K
ORKA▼ Sell$480K
ORKA▼ Sell$26K
ORKA▼ Sell$71K
ORKA▼ Sell$57K
ORKA▼ Sell$28K
ORKA▼ Sell$229K
ORKA▲ Buy$100K
ORKA▲ Buy$50K
ORKA▼ Sell$127K
ORKA▼ Sell$303K
ORKA▲ Buy$25K
ORKA▲ Buy$201K
ORKA▼ Sell$244K
ORKA▼ Sell$272K
ORKA▼ Sell$48K
ORKA▼ Sell$43K
ORKA▼ Sell$16K
ORKA▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.